Recursion Pharmaceuticals, Inc. Class A Common Stock (NASDAQ: RXRX) last traded at $3.50, up 4.79% on the session. The quote above updates while this page is open; the figures below are drawn from Recursion Pharmaceuticals, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Recursion Pharmaceuticals, Inc. Class A Common Stock trades on NASDAQ under the ticker RXRX. Its market capitalisation is $1.87 billion.
Valuation measures for Recursion Pharmaceuticals, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.87B |
|---|---|
| Enterprise value | $1.63B |
| Price / sales | 34.16 |
| Price / book | 2.05 |
| Beta | 2.86 |
Trailing-twelve-month figures tagged in Recursion Pharmaceuticals, Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $54.85M |
|---|---|
| Net income (TTM) | -$518.88M |
| EPS (TTM) | -$1.00 |
| Operating margin | -991.72% |
| Return on equity | -56.71% |
| Cash | $545.68M |
Range and volume for RXRX over the past 52 weeks.
| 52-week high | $7.18 |
|---|---|
| 52-week low | $2.77 |
| Volume | 22.74M |
| Average volume | 20.96M |
| Previous close | $3.34 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.